🇺🇸 FDA
Pipeline program

A three-part trial in healthy volunteers to find out how long icotrokinra stays in and acts on the body when administered as different tablet formulations and under different food conditions

77242113PSO1010

Phase 1 other active

Quick answer

A three-part trial in healthy volunteers to find out how long icotrokinra stays in and acts on the body when administered as different tablet formulations and under different food conditions for Inflammatory Conditions is a Phase 1 program (other) at Janssen-Cilag International N.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Janssen-Cilag International N.V.
Indication
Inflammatory Conditions
Phase
Phase 1
Modality
other
Status
active

Clinical trials